Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDOX-APT: Edoxaban in CAD Patients on DAPT
NCT02567461Phase 4Completed
- Sponsor
- University of Florida
- Start
- Mar 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in coronary artery disease (CAD), sponsored by University of Florida. Started Mar 2016; status: completed.
02
Drugs
edoxaban
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02567461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02567461.